In the European Union,<unk>  must not be used in the following groups: * people receiving another fluoropyrimidine (a group of anticancer medicines that includes<unk>  or who have had severe and unexpected reactions to fluoropyrimidine therapy; * people known to have no DPD enzyme activity, as well as people who, within the previous four weeks, have been treated with a medicine that blocks this enzyme; * pregnant or breastfeeding women; * people with severe leucopenia, neutropenia, or thrombocytopenia (low levels of white cells or platelets in the blood); * people with severe kidney problems requiring dialysis; * people who should not be receiving cisplatin.
Tegafur/gimeracil/oteracil
Trifluridine/tipiracil
Decitabine/cedazuridine
Bicyclomycin
Ethambutol/isoniazid/rifampicin
Trastuzumab/hyaluronidase
Pemetrexed
Isoniazid/pyridoxine/sulfamethoxazole/trimethoprim